E-DRUG Archives (by date)

• Thread Index

January 31, 2002
• [e-drug] HIV/AIDS drug price (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
January 30, 2002
• [e-drug] ARVs - Asian countries' essential drugs lists?
  • From: "Manel Kappagoda" <mkappagoda@ebclc.org>
• [e-drug] HIV/AIDS drug price
  • From: lkasonde@unicef.org
• [e-drug] PM backs veto on subsidising Viagra on Australian PBS
  • From: "Ken Harvey" <k.harvey@bigpond.net.au>
• [e-drug] TAC and MSF import generic ARVs into South Africa
  • From: e-drug@usa.healthnet.org
• [e-drug] Nevirapine donation (cont)
  • From: Gretchen Bachman <GBachman@FHI.org>
• [e-drug] International price information services
  • From: everardm@who.ch
• [e-drug] Drug Formulary (cont)
  • From: "Annalisa Campomori" <a.campomori@ausl.mo.it>
• [e-drug] Drug Price Increase in Pakistan
  • From: Azhar Hussain <azhar@thenetwork.org.pk>
January 29, 2002
• [e-drug] TAC and MSF import generic ARVs into South Africa
  • From: e-drug@usa.healthnet.org
January 28, 2002
• [e-drug] Drug Formulary
  • From: Michelle Ooi <phooi@mail.hukm.ukm.my>
• [e-drug] Codeine in cough mixtures (cont)
  • From: helpline@thenetwork.org.pk
• [e-drug] NGO letter to WTO regarding medical technology exports and
  • From: James Love <love@cptech.org>
• [e-drug] Important Press Alert (28 Jan, 2002)
  • From: Important.Press.Alert (28 Jan, 2002)
• [e-drug] Nevirapine donation (cont)
  • From: "Cecile MACE" <Cecile_MACE@msf.org>
• [e-drug] Identification of counterfeit drugs (cont)
  • From: "Ham, dhr. dr. M. ten" <m.t.ham@minvws.nl>
• [e-drug] Codeine in cough mixtures (cont)
  • From: "FSXXI" <fsxxi@recol.es>
January 27, 2002
• [e-drug] Codeine in cough mixtures (cont)
  • From: "Wong Wai See" <ycwong@brunet.bn>
• [e-drug] Banning of Metamizole in Maldova (cont)
  • From: pharmid@vsnl.net
January 26, 2002
• [e-drug] Identification of counterfeit drugs
  • From: Schleiden-Schmid@medeor.org
• [e-drug] Codeine in cough mixtures (cont)
  • From: VandaZidoniene@VVKT.LT
• [e-drug] Nevirapine donation
  • From: BUKO Pharma-Kampagne <bukopharma@compuserve.com>
• [e-drug] Expensive vaccines not needed? (cont)
  • From: "Wittet, Scott" <swittet@path.org>
January 25, 2002
• [e-drug] Codeine in cough mixtures (cont)
  • From: rtrinkle@mail.pacificcoast.net
January 24, 2002
• [e-drug] Codeine in cough mixtures
  • From: Beverley Snell <bev@burnet.edu.au>
January 23, 2002
• [e-drug] Drug Information Database or system
  • From: Marita van Rooyen <Rooyem@comed.pwv.gov.za>
January 22, 2002
• [e-drug] Request for Sources (2)
  • From: Andy Gray <andy@healthlink.org.za>
January 21, 2002
• [e-drug] URL for Mission drug supply report
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Request for Sources
  • From: Mohamed Gad <mohgad@hotmail.com>
January 20, 2002
• [e-drug] Pharm Ind in Sweden lobbies against PI (2)
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• [e-drug] Use of antimicrobials in fish, animals and plants and
  • From: e-drug@usa.healthnet.org
• [e-drug] HAI statement at WHO Exec Board on Access to Ess Drugs
  • From: hai@hai.antenna.nl
• [e-drug] Expensive vaccines not needed?
  • From: andy@healthlink.org.za
January 19, 2002
• [e-drug] Paroxetine withdrawal symptoms and dependence
  • From: Charles Medawar <charles@socialaudit.org.uk>
• [e-drug] Church based drug supply systems
  • From: Richard Laing <richardl@bu.edu>
January 18, 2002
• [e-drug] Banning metamisole in Moldova (9)
  • From: Sukkari, Sana <ssukkari@jbmh.com>
• [e-drug] Delivery of INRUD News
  • From: Chalker, John <jchalker@msh.org>
• [e-drug] ARV Monitoring tools on the web
  • From: Gregg, Gonsalves <Greggg@gmhc.org>
• [e-drug] Banning metamisole in Moldova (8)
  • From: Jorg Schaaber <bukopharma@compuserve.com>
• [e-drug] Pharm Ind in Sweden lobbies against PI
  • From: Staffan Svensson <staffan.svensson@pharm.gu.se>
• [e-drug] Banning metamisole in Moldova (7)
  • From: Beverley Snell <bev@burnet.edu.au>
January 17, 2002
• [e-drug] Banning metamisole in Moldova (6)
  • From: Sukkari, Sana <ssukkari@jbmh.com>
• [e-drug] Banning metamisole in Moldova (3)
  • From: "Vladimir S. Shoukhov" <shoukhov@cityline.ru>
• [e-drug] Banning metamisole in Moldova (5)
  • From: "Vladimir S. Shoukhov" <shoukhov@cityline.ru>
• [e-drug] Banning metamisole in Moldova (4)
  • From: "Vladimir S. Shoukhov" <shoukhov@cityline.ru>
• [e-drug] Banning metamisole in Moldova (2)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• [e-drug] Availability and price of rofecoxib (9)
  • From: DrugInfo.Moldova" <office@drugs.mldnet.com>"
• [e-drug] Azithromycin sources (8)
  • From: DrugInfo Moldova <office@drugs.mldnet.com>
• [e-drug] Banning metamisole in Moldova
  • From: DrugInfo Moldova <office@drugs.mldnet.com>
• [e-drug] Australian PBS recommends listing Sildenafil citrate
  • From: Ken Harvey <k.harvey@bigpond.net.au>
• [e-drug] Drug Interactions
  • From: Lars Bjerrum <lbjerrum@health.sdu.dk>
January 16, 2002
• [e-drug] Essential drug mission Afghanistan
  • From: "Vladimir S. Shoukhov" <shoukhov@cityline.ru>
• [e-drug] Public heath groups statement to WHO - EB
  • From: Lisa Hayes <lhayes@xs4all.nl>
• [e-drug] women, drugs and trade agreeements
  • From: Elvire Beleoken <educ_actions@yahoo.com>
• [e-drug] Availability and price of rofecoxib (8)
  • From: Daniel Domosbian <cimf@colfarma.org.ar>
• [e-drug] Availability and price of rofecoxib (7)
  • From: Lynn Weekes <LWeekes@nps.org.au>
• [e-drug] Availability and price of rofecoxib (6)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Information on pill usage (3)
  • From: Sharon Mitchell <smitchell@skylark.pharmacy.ualberta.ca>
• [e-drug] Impact of drug policy on anti-microbial resistance (3)
  • From: Ken Harvey <k.harvey@bigpond.net.au>
• [e-drug] Impact of drug policy on anti-microbial resistance (4)
  • From: Warren Kaplan <wak22@mediaone.net>
• [e-drug] Availability and price of rofecoxib (5)
  • From: Vanda Zidoniene <VandaZidoniene@VVKT.LT>
• [e-drug] Impact of drug policy on anti-microbial resistance (2)
  • From: Ham, dhr.dr.M.ten" <m.t.ham@minvws.nl>"
• [e-drug] essential drug mission Afghanistan
  • From: hartlg@who.int
January 15, 2002
• [e-drug] Availability and price of rofecoxib (4)
  • From: Annalisa Campomori <a.campomori@ausl.mo.it>
• [e-drug] Impact of drug policy on anti-microbial resistance
  • From: Kathy Holloway <hollowayk@who.ch>
• [e-drug] Information on pill usage (2)
  • From: <Scott.Hillstrom@manchestercompanies.com>
• [e-drug] Availability and price of rofecoxib (3)
  • From: David Henry <mddah@mail.newcastle.edu.au>
• [e-drug] Availability and price of rofecoxib (2)
  • From: Eggert Sigfusson <eggert.sigfusson@htr.stjr.is>
• [e-drug] Availability and price of rofecoxib
  • From: Ayesha Ahmed <helpline@thenetwork.org.pk>
• [e-drug] Drug Registration in Tonga
  • From: Jean Spinks <youthams@kalianet.to>
• [e-drug] Press Conference at la revue Prescrire Paris, January 24
  • From: Christophe Kopp <Christophe.Kopp@wanadoo.fr>
• [e-drug] Information on pill usage
  • From: Pat Menick <menick@alltel.net>
January 14, 2002
• [e-drug] Position Available at USP
  • From: Nancy Blum <nlb@usp.org>
• [e-drug] Resuing bottles in drug manufacturing (3)
  • From: Michael Anisfeld <manisfeld@globepharm.org>
January 13, 2002
• [e-drug] ARV coordinator needed for Botswana
  • From: e-drug@usa.healthnet.org
• [e-drug] Reusing bottles in the drug manufacturing (2)
  • From: Wong Wai See <yc_waisee@hotmail.com>
January 12, 2002
• [e-drug] DTCA debate heats up in Brussels
  • From: Lisa Hayes <Margaret@hai.antenna.nl>
• [e-drug] Reusing bottles in the drug manufacturing
  • From: e-drug@usa.healthnet.org
• [e-drug] Ouagadougou Appeal
  • From: Olivier Jablonski <jablonski@altern.org>
• [e-drug] Azithromycin sources (7)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
January 11, 2002
• [e-drug] Felicity Mayfield - Tribute
  • From: Bada Pharasi <BPharasi@vhl.co.za>
• [e-drug] Dipyrone (2)
  • From: Ayesha Ahmed <helpline@thenetwork.org.pk>
• [e-drug] RFI-Essential drug lists revised in 2000 & 2001 (2)
  • From: Ayesha Ahmed <helpline@thenetwork.org.pk>
• [e-drug] Azithromycin sources (6)
  • From: Warren Kaplan <wak22@mediaone.net>
• [e-drug] Patent on HIV2 Preventing Licence of Rapid Testing
  • From: Gonsalves, Gregg <Greggg@gmhc.org>
• [e-drug] Patent on HIV2 Preventing Licence of Rapid Testing (2)
  • From: Gonsalves, Gregg <Greggg@gmhc.org>
• [e-drug] Pressure on profits drug companies
  • From: E-drug <e-drug@usa.healthnet.org>
January 10, 2002
• [e-drug] Azithromycin sources (5)
  • From: Carmen PEREZ <Carmen_PEREZ@msf.org>
• [e-drug] Azithromycin sources (4)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• [e-drug] Azithromycin sources (3)
  • From: "Vladimir S. Shoukhov" <shoukhov@cityline.ru>
• [e-drug] Crisis in Argentina
  • From: Carlota Merchán <educacion@prosalus.es>
• [e-drug] Azithromycin sources (2)
  • From: Vanda Zidoniene <VandaZidoniene@VVKT.LT>
• [e-drug] WHO to take over the fight against aids
  • From: Gaelle Krikorian <gerrold@wanadoo.fr>
January 09, 2002
• [e-drug] dipyrone
  • From: Reuven Miller <reuven.miller@moh.health.gov.il>
• [e-drug] azithromycin sources
  • From: Beverley Snell <bev@burnet.edu.au>
January 08, 2002
• [e-drug] Debate on Drug Advertising in Europe
  • From: Lisa Hayes <Lisa@hai.antenna.nl>
January 05, 2002
• [e-drug] RFI-Essential drug lists revised in 2000 & 2001
  • From: Richard Laing <richardl@bu.edu>
January 03, 2002
• [e-drug] Maintaining the integrity of the clinical evidence base (2)
  • From: Tom Poe <tompoe@renonevada.net>
• [e-drug] Pharmacoeconomics - Evidence, Money & Selection
  • From: David Newby <mddan@alinga.newcastle.edu.au>
January 02, 2002
• [e-drug] Maintaining the integrity of the clinical evidence base
  • From: e-drug@usa.healthnet.org